AAREYDRUGS — Aarey Drugs and Pharmaceuticals Balance Sheet
0.000.00%
- IN₹2.51bn
- IN₹2.83bn
- IN₹4.74bn
- 52
- 30
- 87
- 61
Annual balance sheet for Aarey Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 71.4 | 77 | 11.2 | 28.9 | 32.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,620 | 1,363 | 2,004 | 2,000 | 1,684 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,184 | 2,263 | 2,706 | 2,826 | 2,656 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 143 | 145 | 139 | 130 | 162 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,330 | 2,452 | 2,913 | 3,033 | 2,906 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,326 | 1,301 | 1,681 | 1,665 | 1,492 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,342 | 1,315 | 1,739 | 1,705 | 1,521 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 989 | 1,136 | 1,174 | 1,328 | 1,385 |
| Total Liabilities & Shareholders' Equity | 2,330 | 2,452 | 2,913 | 3,033 | 2,906 |
| Total Common Shares Outstanding |